His-FemA融合蛋白表达载体的构建及其在原核细胞中的表达

目的 构建His标签的金黄色葡萄球菌甲氧西林耐药相关蛋白FemA的融合蛋白表达载体,并在大肠埃希菌中表达,为进一步研究femA基因的生物学功能和临床应用奠定基础.方法 根据GenBank中金黄色葡萄球菌femA基因序列,利用Primer Premier 5.0设计PCR引物,并在引物的5'加入BamHI及SalI酶切位点;以金黄色葡萄球菌基因组DNA为模版,PCR扩增出femA基因片段.将目的DNA片段及质粒pQE30分别进行双酶切、连接并转化大肠埃希菌DH5α;阳性克隆以PCR、双酶切及测序进行鉴定.将鉴定正确的pQE30-femA重组质粒转化大肠埃希菌JM109,异丙基-β-D-硫代半乳糖苷(IPTG)诱导表达His-femA融合蛋白;采用SDS-PAGE及Western blot分析对表达蛋白进行验证.结果 经PCR、双酶切签定及序列测定,证实重组质粒pQE30-femA构建成功;重组质粒pQE30-femA转化大肠埃希菌JM109经IPTG诱导后,SDS-PAGE和Western blot分析显示表达出53 kD目的蛋白;经Bandscan软件分析,目的蛋白质在4h的表达量占细胞总蛋白的27.5％.结论 成功构建了His-FemA原核表达载体(pQE30-femA),并在大肠埃希菌中高效表达.     

肺炎支原体重组蛋白抗原的初步鉴定

克隆并表达肺炎支原体(Mycoplasma pneumoniae,Mp)P1黏附蛋白D-2区基因片段,进而对重组蛋白的抗原特异性进行鉴定。应用PCR技术获取目的基因片段,并构建含有目的基因片段的重组质粒,用重组质粒酶切图谱法、PCR扩增及核苷酸测序方法鉴定重组质粒。而后将其转入大肠杆菌BL21菌株,用IPTG诱导目的基因表达,用SDS-PAGE分析重组蛋白的相对分子量,免疫印迹实验鉴定其免疫反应性,并用ELISA实验测定重组蛋白抗原的特异性。结果重组质粒中的p1基因片段经测序后,与GenBank中p1基因核苷酸序列比较,其同源性为99.66%~100%;经SDS-PAGE分析,重组蛋白的相对分子量约为59 ku;免疫印迹实验和ELISA实验证实,Mp免疫血清和Mp感染患者血清都能与重组蛋白发生特异反应。研究中的含P1黏附因子D-2区基因的重组质粒已成功构建,其表达的重组蛋白具有特异的免疫反应性,初步ELISA实验证实,本研究获得的重组蛋白可用于临床标本检测。     

阴道毛滴虫铁氧还蛋白基因的原核表达

目的在原核细胞中表达阴道毛滴虫铁氧还蛋白(ferredoxin,Fd)基因。方法构建阴道毛滴虫Fd基因的原核表达重组质粒pUC19-Fd,转化大肠埃希菌JM109感受态细胞中,异丙基-β-D-硫代半乳糖苷(IPTG)诱导蛋白质表达。结果经十二烷基磺酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)和免疫印迹(Western blot)分析,重组质粒在大肠埃希菌中表达出Fd。结论在大肠埃希菌中表达出了Fd。     

阴道毛滴虫黏附蛋白65-3基因原核表达质粒的构建及表达

质粒 pMD-18T-ap65-3 经 Xho I 和 BamH I 双酶切, 1.0% 凝胶电泳后纯化回收阴道毛滴虫黏附蛋白 65-3 基因,定向克隆至原核表达载体 pET-32a( ), 构建原核表达质粒 pET32a-ap65-3. 重组质粒转化大肠埃希菌 JM109 感受态细胞中, 筛选阳性克隆, 进行PCR﹑酶切及测序鉴定正确后, 将重组质粒 pET32a-ap65-3 转化于大肠埃希菌 BL21 中,异丙基-β-D硫代半乳糖苷 (IPTG) 诱导重组蛋白表达后利用十二烷基磺酸钠一聚丙烯酰胺凝胶电泳 (SDS-PAGE) 和免疫印迹 (Western blot) 对重组蛋白进行分析鉴定. 本实验为研究阴道毛滴虫病的致病机制及蛋白生物学功能奠定了基础.     

狂犬病病毒糖蛋白在大肠埃希菌中的表达及鉴定

目的表达狂犬病病毒糖蛋白（GP）,用于狂犬病疫苗免疫抗体评估和狂犬病病毒糖蛋白功能的研究。方法采用分析软件,分析其可能的抗原表位,利用PCR方法扩增狂犬病病毒SRV9疫苗株G蛋白抗原位点区域基因,PCR产物经EcoRI和SalI双酶切后,插入大肠埃希菌表达载体pGEX-6P-1,构建重组表达质粒pGEX-6P-1/G87a和pGEX-6P-1/G100a。将重组质粒转化大肠埃希菌BL21感受态细胞中,在IPTG诱导下表达目的蛋白,进行SDS-PAGE分析。表达蛋白进行电洗脱纯化和Western blot鉴定分析。结果成功构建了pGEX-6P-1/G87a和pGEX-6P-1/G100a表达质粒,序列分析表明,插入片段大小分别为1314 bp和1275 bp。SDS-PAGE分析结果证明,在大肠埃希菌系统中成功表达了狂犬病病毒部分糖蛋白,表达的融合蛋白含有GST标签,大小分别约为74×103和73×103。Western blot鉴定结果表明,表达产物有抗原特异性并能与狂犬病病毒抗血清反应。结论利用大肠埃希菌表达系统成功表达了狂犬病病毒部分糖蛋白,表达产物有良好的反应原性。     

结核分枝杆菌19kD-ESAT6融合蛋白的克隆表达及纯化

运用聚合酶链反应( PCR) 技术从结核分枝杆菌标准株H37Rv 中扩增获得19kD 脂蛋白和esat-6 基因片段, 将目的片段分别克隆到pMD18-T 载体, 再亚克隆目的片段到同一表达载体pET-21a, 构建重组表达载体pET21a-19kD-ESAT6, 转化至大肠埃希菌BL21( DE3) , 表达纯化后用蛋白质印迹法( Western blot) 分析其抗原反应性。结果成功构建了重组质粒pET21a-19kD-ESAT6, 并在大肠埃希菌中获得高效表达。SDS-PAGE 结果显示, 在相对分子质量( Mr) 约29 ×103 处有表达条带。estern blot 结果表明, 重组蛋白19kD-ESAT6 与确诊的结核病患者血清发生特异性免疫反应, 具有特异的抗原性。本研究构建的结核分枝杆菌19kD-ESAT6 融合蛋白为结核病血清学诊断试剂的开发提供了依据。     

CTX-M-14型超广谱β-内酰胺酶的序列分析与原核表达

目的对大肠埃希菌所产CTX-M-14型超广谱β-内酰胺酶（ESBLs）进行基因克隆和重组表达,探讨其特性。方法以产CTX-M-14型超广谱β-内酰胺酶大肠埃希菌12号菌总基因组DNA为模板,PCR扩增CTX-M-14,将其克隆入pUCm-T Vector载体后测定该核苷酸序列;再将基因编码区克隆到原核表达载体pET-28α,构建含CTX-M-14基因的重组表达质粒,转化到大肠埃希菌BL21中进行IPTG诱导表达。SDS-PAGE电泳鉴定表达的酶蛋白后再过Ni-NTA柱纯化。结果PCR扩增出大小为876bp的基因片段,与GenBank上同类酶的基因序列同源性为100％。大肠埃希菌BL21转化pET-28a／CTX-M-14重组质粒后,ESBLs试验为阳性。此基因能在大肠埃希菌中大量表达,SDS-PAGE电泳显示蛋白分子质量大约为30KD。结论成功表达重组的CTX-M-14型酶,为进一步做酶动力学及酶的其他分子生物学特性研究奠定基础。     

重组肺炎支原体CARDS毒素蛋白临床检测应用的初步研究

目的初步探讨肺炎支原体CARDS毒素蛋白在检测肺炎支原体感染中的应用价值。方法 PCR扩增CARDS毒素基因并连接到PMD-19-T载体,经酶切、PCR及核苷酸测序分析后,将CARDS毒素基因片段克隆到pGEX-6p-1表达载体内并转入受体菌。IPTG诱导大肠埃希菌BL21重组株(pGEX-6p-1-CARDS)的表达。GST柱层析纯化重组CARDS毒素蛋白,以该重组蛋白和重组P1蛋白为抗原建立间接ELISA方法,检测85份感染肺炎支原体的血清标本,并与重组P1蛋白的ELISA结果进行比较。结果 CARDS毒素蛋白表达载体构建成功并表达大小为43kDa的重组蛋白,Western blot测定其能与兔抗Mp多价抗血清发生反应。ELISA结果显示,CARDS毒素蛋白的阳性率为70.59%(60/85),重组P1蛋白的阳性率为63.53%(54/85)。结论本研究成功构建了CARDS毒素蛋白表达载体并获得了稳定表达的重组菌株;在诊断肺炎支原体感染的血清学ELISA试验中,重组CARDS毒素蛋白的敏感性高于重组P1蛋白,为Mp感染的诊断提供了新的可用抗原。     

恶性疟P190抗原基因的表达及免疫学研究

克隆了我国海南省FCCl／HN株P190抗原三肽重复区基因,定名为P190TR。该基因片段经DNA序列分析鉴定后连接到改建的pGEx一2T表达载体BamHⅠ和xbaⅠ位点中,经鉴定的重组质粒转化感受态JM109(DE3)大肠杆菌进行表达。结果显示：该基因得到高效融合表达．经一步亲和纯化后就取得高纯度的重组蛋白。用纯化的表达蛋白免疫动物亦产生P190TR特异性抗体。     

CMY-39型AmpC酶新基因亚型的序列分析与原核表达

目的对弗劳地枸橼酸杆菌所产CMY-39型AmpC酶新基因亚型进行基因克隆和重组表达。方法以产CMY-39型AmpC酶新基因亚型的弗劳地枸橼酸杆菌总基因组DNA为模板,PCR扩增CMY-39,将其克隆入pGEM-T载体后测定该核苷酸序列,再将CMY-39基因克隆到pET-32 a（＋）系统进行重组,重组菌在大肠埃希菌BL21中表达,SDS-PAGE电泳鉴定酶蛋白的表达。结果 PCR扩增出大小为1 146 bp的基因片段,与GenBank上CMY-39的基因序列同源性为99%。大肠埃希菌BL21转化pET-32 a（＋）/CMY-39重组质粒后,AmpC酶三维试验为阳性。此基因能在大肠埃希菌中大量表达,SDS-PAGE电泳显示,蛋白分子质量大约为60 kD。结论此基因为CMY-39新基因亚型,登陆号为HM565135;成功表达重组的CMY-39型酶,为进一步做酶动力学及酶的其他分子生物学特性研究奠定了基础。     

密码子优化的肺炎支原体P1蛋白在大肠杆菌中的克隆表达

目的:获得密码子优化的肺炎支原体P1黏附蛋白优势表位抗原基因,并在大肠杆菌中表达,为临床诊断试剂和疫苗研制打下基础。方法:采用生物信息学分析肺炎支原体P1蛋白的抗原表位,筛选特异性P1蛋白优势表位区;采用大肠杆菌优势密码子,设计上述P1蛋白优势表位基因序列;采用退火PCR技术合成上述基因,并利用载体pGEX-4T-2实现P1优势表位抗原在大肠杆菌中的表达;采用ELISA法对纯化的P1抗原活性进行测定。结果:肺炎支原体P1蛋白特异性抗原表位主要位于1154~1521 aa,获得的P1优化密码子基因平行突变37个稀有密码子和2个终止密码子;在大肠杆菌中表达的GST-P1融合蛋白的相对分子质量为65.9×103,纯化后重组抗原能与肺炎支原体感染者血清发生特异性的免疫反应。结论:采用密码子优化基因合成技术实现了肺炎支原体P1优势表位抗原在大肠杆菌中的高效表达,为肺炎支原体感染的诊断试剂研究提供了重要参考。     

肺炎支原体P1重组蛋白的提取纯化及应用研究

提取纯化肺炎支原体(Mycoplasma pneumoniae,Mp)P1重组蛋白,建立酶联免疫吸附实验(ELISA)的方法,协助临床肺炎支原体感染的诊断。以GST融合蛋白层析柱提取、纯化Mp P1重组蛋白做抗原,以全肺炎支原体菌体成分做抗原对照,建立间接ELISA实验方法,检测40份正常献血者血清标本和51份疑似MP感染临床血清标本的IgG抗体。重组蛋白经SDS-PAGE可见诱导表达的样品在分子量大约59 ku处有明显条带,经Western blotting可与肺炎支原体免疫血清发生反应。ELISA实验检测51份临床标本,由P1重组蛋白抗原检测阳性31份,阳性率为60.78%。Mp检测阳性20份,阳性率为39.22%。实验精确度检测阳性混合血清的变异系数(CV值)为5.40%,阴性混合血清变异系数为1.10%。用Mp P1重组蛋白抗原建立的ELISA检测方法,其敏感性高于全肺炎支原体抗原,可用于临床肺炎支原体感染的诊断。     

In vivo function of airway epithelial TLR2 in host defense against bacterial infection

Decreased Toll-like receptor 2 (TLR2) expression has been reported in patients with chronic obstructive pulmonary disease and in a murine asthma model, which may predispose the hosts to bacterial infections, leading to disease exacerbations. Since airway epithelial cells serve as the first line of respiratory mucosal defense, the present study aimed to reveal the role of airway epithelial TLR2 signaling to lung bacterial [i.e., Mycoplasma pneumoniae (Mp)] clearance. In vivo TLR2 gene transfer via intranasal inoculation of adenoviral vector was performed to reconstitute TLR2 expression in airway epithelium of TLR2(-/-) BALB/c mice, with or without ensuing Mp infection. TLR2 and lactotransferrin (LTF) expression in airway epithelial cells and lung Mp load were assessed. Adenovirus-mediated TLR2 gene transfer to airway epithelial cells of TLR2(-/-) mice reconstituted 30-40% TLR2 expression compared with TLR2(+/+) cells. Such airway epithelial TLR2 reconstitution in TLR2(-/-) mice significantly reduced lung Mp load (an appropriate 45% reduction), coupled with elevated LTF expression. LTF expression in mice was shown to be mainly dependent on TLR2 signaling in response to Mp infection. Exogenous human LTF protein dose-dependently decreased lung bacterial load in Mp-infected TLR2(-/-) mice. In addition, human LTF protein directly dose-dependently decreased Mp levels in vitro. These data indicate that reconstitution of airway epithelial TLR2 signaling in TLR2(-/-) mice significantly restores lung defense against bacteria (e.g., Mp) via increased lung antimicrobial protein LTF production. Our findings may offer a deliverable approach to attenuate bacterial infections in airways of asthma or chronic obstructive pulmonary disease patients with impaired TLR2 function.     

肺炎支原体感染鼠P1特异抗原的动态检测

通过实验动物模型探讨肺炎支原体感染动物肺泡灌洗液中特异抗原检出率的动态变化,为肺炎支原体感染的临床诊断提供理论依据。小鼠经鼻自然感染肺炎支原体,分别采集感染后不同时间点小鼠的支气管灌洗液,应用量子点标记肺炎支原体P1蛋白抗体,直接免疫荧光法检测感染鼠肺泡灌洗液中肺炎支原体P1特异抗原,同时通过PCR检测肺组织肺炎支原体DNA及肺组织病理切片观察肺部炎性变化确定小鼠感染。结果显示,感染鼠肺炎支原体特异抗原在感染后第3天检出阳性率为75%,第7天达高峰为83%,之后随病程延长,抗原检测的阳性率逐渐下降,在感染后第14、21天检出阳性率分别为58%和25%。肺炎支原体特异抗原在感染早期检出率高。应用量子点标记肺炎支原体P1蛋白抗体,直接免疫荧光法检测肺炎支原体特异抗原可应用于肺炎支原体感染的早期诊断。     

恶性疟原虫子孢子CS抗原融合基因的克隆

利用381-A型DNA合成仪,参照恶性疟原虫子孢子CS抗原决定簇相应氨基酸的核苷酸序列,设计了CS-Ⅰ和CS-Ⅱ两个片段。以噬菌体M13mp18质粒作为载体,将两片段进行磷酸化、退火、连接和克隆,经过原位杂交,序列分析,获得了(NANP)_(10)重复串联基因的重组质粒M13mp18-CS。再以酶切,从重组质粒中回收(NANP)_(10)次的片段,将其片段基因与CT-B基因融合,最后将融合基因CT-B-CS插入载体PMC055中,成功地得到含有(NANP)_(10)与CT-B基因融合的重组质粒pMC055-CS。     

Construction and application of epitope- and green fluorescent protein-tagging integration vectors for Bacillus subtilis

Here we describe the construction and application of six new tagging vectors allowing the fusion of two different types of tagging sequences, epitope and localization tags, to any Bacillus subtilis protein. These vectors are based on the backbone of pMUTIN2 and replace the lacZ gene with tagging sequences. Fusion of the tagging sequences occurs by PCR amplification of the 3' terminal part of the gene of interest (about 300 bp), insertion into the tagging vector in such a way that a fusion protein will be synthesized upon integration of the whole vector via homologous recombination with the chromosomal gene. Three of these tagging sequences (FLAG, hemagglutinin, and c-Myc) allow the covalent addition of a short epitope tag and thereby detection of the fusion proteins in immunoblots, while three other tags (green fluorescent protein(+), yellow fluorescent protein, and cyan fluorescent protein) are helpful in assigning proteins within one of the compartments of the cell. The versatility of these vectors was demonstrated by fusing these tags to the cytoplasmically located HtpG and the inner membrane protein FtsH.     

含preS2免疫表位的HBsAg基因质粒的构建及表达

目的：应用表位设计构建高效表达乙型肝炎表面抗原含preS2免疫原位基因的真核表达质粒。方法：PCR法从慢性乙型肝炎患者血清中扩增和分离preS2 120-146表位和S基因片段,将两者融合并置于载体pcDNA3.1的巨细胞病（CMV）启动子作用之下,构建真核表达质粒pcDNA-S2S。序列分析和脂质体转染COS-7细胞瞬时表达鉴定。结果：序列测定结果表明插入序列与乙型肝炎病毒中国株全基因参照序列（adr亚型）一致,COS-7细胞瞬时表达鉴定实验中,ELISA检测到preS2-Ag和HBsAg的OD450分别为0.469和0.426。结论：应用表位设计成功地构建了含preS2免疫表位基因的重组质粒pcDNA-S2S所构建质粒能高效表达和分泌目的的蛋白。     

Association of a 33-kilodalton cysteine proteinase found in corn callus with the inhibition of fall armyworm larval growth.

Protein patterns of callus from corn (Zea mays L.) inbreds that are either resistant or susceptible to fall armyworm (Spodoptera frugiperda [J.E. Smith]) were analyzed by two-dimensional electrophoresis. Fall armyworm larvae reared on callus initiated from resistant inbreds were significantly smaller than those reared on callus of susceptible inbreds. A 33-kD protein found in callus from the resistant inbreds Mp704 and Mp708 was absent in callus from the susceptible inbreds Tx601 and Ab24E. However, a 36-kD protein found in Ab24E callus immunoreacted with polyclonal antibody raised against the 33-kD protein. When Mp704 nonfriable callus changed to friable, larval growth was not inhibited and the 33-kD protein was absent. There was a significant negative correlation between the concentration of the 33-kD protein in the callus and the weight of the larvae feeding on the callus in the F2 progeny of Mp704 x Tx601. The N-terminal amino acid sequence of the 33-kD protein suggested that it was cysteine proteinase. Purification of the 33- (Mp708) and 36-kD (Ab24E) proteins indicated that they were both cysteine proteinases. The 33-kD cysteine proteinase had 7-fold higher specific activity than the 36-kD enzyme.     

Immunohistochemical detection of mutant p53 protein in regional lymph nodes is associated with adverse outcome in stage II colorectal cancer

Epidemiologic data identifies a cohort of Duke's B (CRC) patients whose survival more closely matches that of Duke's C. Lymph node micrometastases may account for this discrepancy. Lymph node expression of mutant p53 protein (Mp53P) has been linked to a reduction in survival in Japanese Duke's B patients. We aimed to determine the significance of nodal p53 expression in European Duke's B patients using immunohistochemistry. The study comprised 134 consecutive patients who had resections for CRC between 1984 and 1991. End points were 5 year disease free survival or CRC related death. Thirty-four subjects did not achieve end points and were excluded. We examined tumour and nodal sections for Mp53P by immunohistochemistry and correlated this with survival using a Kaplan-Meier (KM) and a Cox Proportional hazards model (CPHT). Five year survival was 73%. Fifty-eight percent of primary tumours expressed Mp53P. Tumour p53 expression did modulate survival behavior. Twenty-six percent of subjects' lymph nodes expressed Mp53P. Fifty-three per cent of those with positive and 17% of those with negative lymph nodes died of recurrence. The relative risk for nodal Mp53P expression was 3.1. There was a significant univariate relationship between lymph node p53 expression and mortality. (Log Rank p = 0.028). Multivariate analysis also showed a significant relationship with mortality. (CPHT p = .03). We conclude that lymph node expression of Mp53P is associated with increased mortality in Duke's B CRC.